![]() |
市場調査レポート
商品コード
1562506
薬局の市場規模、シェア、成長分析、製品別、薬局別、地域別 - 産業予測、2024年~2031年Pharmacy Market Size, Share, Growth Analysis, By Product(OTC, Prescription), By Pharmacy (hospital pharmacy, retail pharmacy), By Region - Industry Forecast 2024-2031 |
||||||
|
薬局の市場規模、シェア、成長分析、製品別、薬局別、地域別 - 産業予測、2024年~2031年 |
出版日: 2024年09月11日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
|
世界の薬局の市場規模は、2022年に約1兆2,000億米ドルとなり、2023年の1兆2,500億米ドルから上昇し、予測期間(2024年~2031年)のCAGRは7.3%で、2031年までには2兆2,000億米ドルに達すると予測されています。
世界の薬局市場は、小売薬局、オンライン薬局、医薬品流通ネットワークを包含し、力強い成長を遂げています。この市場拡大の背景には、世界人口の高齢化、慢性疾患の蔓延、ヘルスケアサービスに対する需要の増加があります。遠隔医療やe-薬局プラットフォームの革新は、従来の薬局モデルを変革し、利便性を提供し、医薬品へのアクセスを向上させています。さらに、現在進行中のCOVID-19パンデミックはデジタル変革を加速させ、より多くの消費者が直接の接触を避けるためにオンライン薬局を選んでいます。AIを活用した処方箋管理や個別化医療といったテクノロジーの統合も、この分野の進化に寄与しています。しかし、市場は規制上の制約、価格圧力、ブランド医薬品よりもジェネリック医薬品重視の高まりといった課題に直面しています。今後5年間の年間平均成長率(CAGR)は約5%から7%と予測されており、薬局市場は、技術の進歩、消費者行動の変化、ヘルスケアへのアクセス重視の高まりなどを背景に、継続的な成長が見込まれています。
Global Pharmacy Market size was valued at around 1.2 trillion in 2022 and is expected to rise from USD 1.25 trillion in 2023 to reach a value of USD 2.2 trillion by 2031, at a CAGR of 7.3% over the forecast period (2024-2031).
The global pharmacy market, which encompasses retail pharmacies, online pharmacies, and pharmaceutical distribution networks, is experiencing robust growth. This market expansion is driven by an aging global population, the rising prevalence of chronic diseases, and an increasing demand for healthcare services. Innovations in telemedicine and e-pharmacy platforms are transforming the traditional pharmacy model, offering convenience and enhancing access to medications. Furthermore, the ongoing COVID-19 pandemic has accelerated digital transformation, with more consumers opting for online pharmacies to avoid in-person contact. The integration of technology, such as AI-driven prescription management and personalized medicine, also contributes to the sector's evolution. However, the market faces challenges, such as regulatory constraints, pricing pressures, and a growing emphasis on generic drugs over branded pharmaceuticals. With a projected compound annual growth rate (CAGR) of around 5-7% in the next five years, the pharmacy market is poised for continuous growth, driven by technological advancements, consumer behavior shifts, and an increasing focus on healthcare accessibility.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmacy Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pharmacy Market Segmental Analysis
Global Pharmacy Market is segmented by Product Type and Pharmacy Type, and region. Based on Product Type, the market is segmented into OTC and prescription. Based on Pharmacy Type, the market is segmented into Hospital Pharmacy, Retail Pharmacy (Chain, Independent, Others), E-Pharmacy and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Drivers of the Global Pharmacy Market
The rise of e-pharmacies is a significant driver in the global pharmacy market. With the growing penetration of the internet and smartphones, consumers are increasingly turning to online platforms for their pharmaceutical needs. E-pharmacies offer a convenient and cost-effective alternative to traditional brick-and-mortar pharmacies, especially for those with limited mobility or living in remote areas. They provide a broader range of products, including prescription medicines, over-the-counter drugs, and healthcare essentials, often at competitive prices. The COVID-19 pandemic has further accelerated the adoption of e-pharmacies due to social distancing measures and the need for contactless delivery. Additionally, e-pharmacies leverage technology such as AI and machine learning to offer personalized services, like reminders for refills and tailored healthcare advice. As a result, the e-pharmacy sector is expected to continue expanding, contributing significantly to the growth of the overall pharmacy market.
Restraints in the Global Pharmacy Market
Regulatory challenges remain a key restraint in the global pharmacy market. The pharmaceutical industry is heavily regulated to ensure patient safety, drug efficacy, and compliance with local laws and international standards. These regulations vary significantly across different regions and countries, creating complexities for market players looking to expand or operate globally. Stringent regulations related to drug approval processes, sales, and distribution can lead to delays in product launches and increased costs for companies. E-pharmacies, in particular, face additional scrutiny concerning the sale of prescription drugs, cross-border transactions, and the management of patient data privacy. Non-compliance with regulatory requirements can result in hefty fines, product recalls, and even bans, impacting the reputation and profitability of businesses. Thus, navigating the evolving regulatory landscape remains a significant challenge for the market's growth.
Market Trends of the Global Pharmacy Market
Personalized medicine is an emerging trend reshaping the pharmacy market. This approach tailors medical treatment to the individual characteristics of each patient, taking into account genetic, environmental, and lifestyle factors. The increasing availability of genetic testing and advancements in biotechnology have made it possible to develop personalized therapies that are more effective and have fewer side effects compared to conventional treatments. Pharmacies are adapting by offering services that align with personalized healthcare, such as pharmacogenomics consultations and customized medication plans. Digital tools, like AI-driven algorithms, are further enhancing the ability to predict patient responses to specific medications. As personalized medicine becomes more prevalent, pharmacies that integrate these offerings into their service models stand to gain a competitive advantage, tapping into a growing segment of patients seeking individualized care options.